Citations 2
441 | GOLCADOMIDE, A CEREBLON E3 LIGASE MODULATOR (CELMoD) AGENT ± RITUXIMAB, IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: UPDATED PHASE 1/2 RESULTS
Cordoba, R., Perini, Guilherme Fleury , Jørgensen, Judit , Bijou, Fontanet , Munoz, J., Kim, W. S., Rao, P. , Moucheron, Bérengère de, Yang, Gang , Carrancio, Soraya , Sudhindra, Akshay, Voetsch, Jessica, Cordoba, R., Chavez, Julio C , Nastoupil, Loretta J. , Bories, Pierre , Zinzani, Pier Luigi , Munoz, J., Carpio, Cecilia del Carmen , Costa, Alfredo Cardoso , Pourdehnad, Michael , Michot, Jean‐Marie
Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available
S200: IMPROVED OVERALL SURVIVAL WITH FIRST-LINE BRENTUXIMAB VEDOTIN PLUS CHEMOTHERAPY IN PATIENTS WITH STAGE III/IV CLASSICAL HODGKIN LYMPHOMA: 6-YEAR ANALYSIS OF ECHELON-1
Ansell, S., Straus, David J. , Kim, W. S., Gallamini, Andrea , Ramchandren, Radhakrishnan , Friedberg, Jonathan W. , Eom, Hyeon‐Seok , Dong, C., Campana, Frank, Fenton, Keenan , Puhlmann, Markus , Hutchings, Martin , Connors, Joseph M. , Advani, Ranjana H. , Evens, Andrew M. , Smolewski, Piotr , Savage, Kerry J. , Bartlett, Nancy L. , Abramson, Jeremy S. , Radford, John
HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 101-102